Advanced search
Publication Cover
Cancer Investigation Volume 14, 1996 - Issue 4
Submit an article Journal homepage
8
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Interleukin-3 plus Low-Dose Cytosine Arabinoside for Advanced Myelodysplasia: A Pilot Study

Heinrich H. Gerhartz Med. Dept. III, Klinikum Grosshadern, Germany
,
Heinz H. Zwierzina Med. Dept., Innsbruck University, Austria
,
Jochem Walther Med. Dept. III, Klinikum Grosshadern, Germany
,
Pierre Fenaux Centre Hospit, Lille, France
,
Marcel Hayat Inst. Gustave Roussy, Villejuif, France
,
Allen Jacobs Med. Dept., Cardiff University, United Kingdom
,
A. Victor Hoffbrand The Royal Free Hospital, London, United Kingdom
,
Murielle Dardenne EORTC Data Center, Brussels, Belgium
,
Gabriel Solbu EORTC Data Center, Brussels, Belgium
,
Stefan Suciu EORTC Data Center, Brussels, Belgium
,
Sergio Amadori Cattedra di Ematologia, Rome, Italy
&
Roel Willemze Acad. Ziekenhuis, Leiden, The Netherlands
 show all
Pages 299-306 | Published online: 11 Jun 2009

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Judith E Karp & Clarence Sarkodee-Adoo. (1999) Molecular therapeutics of myelodysplasia and myelodysplasia-related leukaemias. Emerging Therapeutic Targets 3:1, pages 151-163.
Read now

Articles from other publishers (6)

H Zwierzina, S Suciu, J Loeffler-Ragg, R Neuwirtova, P Fenaux, M Beksac, J Harousseau, V Nuessler, J Cermak, G Solbu, R Willemze, T de Witte & S Amadori. (2005) Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group. Leukemia 19:11, pages 1929-1933.
Crossref
F FOSS. (2004) Nucleoside analogs and antimetabolite therapies for myelodysplastic syndrome. Best Practice & Research Clinical Haematology 17:4, pages 573-584.
Crossref
Peter Valent, Friedrich Wimazal, Ilse Schwarzinger, Wolfgang R. Sperr & Klaus Geissler. (2003) Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS)Pathogenese, Klassifikation und Therapie der myelodysplastischen Syndrome. Wiener Klinische Wochenschrift 115:13-14, pages 515-536.
Crossref
Peter A. Kouides & John M. Bennett. 1999. Diagnostic and Therapeutic Advances in Hematologic Malignancies. Diagnostic and Therapeutic Advances in Hematologic Malignancies 335 362 .
Valeria Santini & Pierluigi Rossi Ferrini. (2008) DIFFERENTIATION THERAPY OF MYELODYSPLASTIC SYNDROMES: FACT OR FICTION?. British Journal of Haematology 102:5, pages 1124-1138.
Crossref
Peter A. Kouides & John M. Bennett. (1997) Understanding the Myelodysplastic Syndromes. The Oncologist 2:6, pages 389-401.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.